Comparing Bariatric Surgery Outcomes in Predominantly High-Risk Asian Patients to Global Benchmarks

October 20, 2024 updated by: National University Hospital, Singapore

Comparing Bariatric Surgery Outcomes in Predominantly High-Risk Asian Patients to Global Benchmarks: Insights From a Decade-Long Cohort Study of 1016 Patients

While metabolic-bariatric surgery is a safe and well-established surgery, complications do occur and can have significant impact on the patient. With the study, the investigators aim to establish the proportion of patients that will have complications and understand what the impact of complications are on costs.

Study Overview

Status

Completed

Detailed Description

Complications after metabolic-bariatric surgery can be catastrophic and have significant impact on costs, morbidity, and mortality. As current global benchmarks for complications rates in MBS are based on standard risk patients in western populations, the benchmark complication rates in high-risk patients and Asian populations are unknown. The investigators aim to evaluate the incidence of complications in 1016 consecutive patients and the impact of complications on costs.

Study Type

Observational

Enrollment (Actual)

1016

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 119074
        • National University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Our patients are consecutive patients that underwent metabolic-bariatric surgery.

Description

Inclusion Criteria:

  • The inclusion criteria were patients who underwent either primary or revisional MBS comprising Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass (RYGB) or One-Anastomosis Gastric Bypass (OAGB).

Exclusion Criteria:

  • Patients under 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Metabolic-Bariatric Surgery
Patients undergoing Metabolic-Bariatric Surgery are divided into either Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass (RYGB) or One-Anastomosis Gastric Bypass (OAGB).
Our study is conducted in a predominantly high-risk Asian population that will be undergoing metabolic-bariatric surgery. The types of surgery can be divided into Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass (RYGB) or One-Anastomosis Gastric Bypass (OAGB).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with Anastomotic Leak
Time Frame: From completion of surgery till post-operative 90 days
90 Day Post-Operative Complications
From completion of surgery till post-operative 90 days
Number of Participants with Bleeding
Time Frame: From completion of surgery till post-operative 90 days
90 Day Post-Operative Complications
From completion of surgery till post-operative 90 days
Number of Participants with Perforation
Time Frame: Time Frame: From completion of surgery till post-operative 90 days
90 Day Post-Operative Complications
Time Frame: From completion of surgery till post-operative 90 days
Number of Participants with Collection
Time Frame: Time Frame: From completion of surgery till post-operative 90 days
Collection includes hematoma, pus, serous fluids. Outcome measured to 90 Day Post-Operative.
Time Frame: From completion of surgery till post-operative 90 days
Number of Participants with Hospital Readmission
Time Frame: From completion of surgery till post-operative 90 days
Any readmission to hospital from completion of surgery till post-operative 90 days
From completion of surgery till post-operative 90 days
Number of Participants with Reoperation
Time Frame: From completion of surgery till post-operative 90 days
Any reoperation due to any complications from completion of surgery till post-operative 90 days
From completion of surgery till post-operative 90 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Costs of Bariatric Surgery (USD)
Time Frame: From completion of surgery till post-operative 90 days
Total costs of all events that occur from surgery till post-operative 90 days will be included. Costs will be extracted from hospital records.
From completion of surgery till post-operative 90 days
Time to surgical intervention (hr)
Time Frame: From completion of surgery till 90 days post-operative
Time to surgical intervention for patients requiring surgical treatment for post-operative complications. Time will be extracted from surgical records
From completion of surgery till 90 days post-operative
Number of Participants with Total Parental Nutrition Requirement
Time Frame: From completion of surgery till post-operative 90 days
Use of Total Parental Nutrition during 90 Day Post-Operative
From completion of surgery till post-operative 90 days
Number of Participants with Blood Transfusion
Time Frame: From completion of surgery till post-operative 90 days
Any blood transfusion given from completion of surgery till post-operative 90 days
From completion of surgery till post-operative 90 days
Length of Stay (Days)
Time Frame: From completion of surgery till hospital discharge assessed up to post-operative 90 days
Length of hospital stay from index operation to hospital discharge
From completion of surgery till hospital discharge assessed up to post-operative 90 days
Number of Participants with Emergency Department Attendance
Time Frame: From completion of surgery till post-operative 90 days
Any Emergency Department Attendance from completion of surgery till post-operative 90 days
From completion of surgery till post-operative 90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Asim Shabbir, MBBS, FRCS, National University Hospital, Singapore

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2010

Primary Completion (Actual)

February 1, 2023

Study Completion (Actual)

April 1, 2023

Study Registration Dates

First Submitted

October 8, 2024

First Submitted That Met QC Criteria

October 14, 2024

First Posted (Actual)

October 21, 2024

Study Record Updates

Last Update Posted (Actual)

October 23, 2024

Last Update Submitted That Met QC Criteria

October 20, 2024

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data will be shared upon reasonable request towards corresponding author.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complications

Clinical Trials on Metabolic-bariatric surgery

Subscribe